Neurocrine Biosciences, Inc. Selects PANTHERx®Rare Specialty Pharmacy for Distribution of Crenessity™ (crinecerfont)
December 20th, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services...
Read More
Ascendis Pharma Selects PANTHERx® Rare for the Distribution of YORVIPATH® (palopegteriparatide)
December 6th, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services...
Read More
BridgeBio Selects PANTHERx®Rare Specialty Pharmacy for Distribution of Attruby™ (acoramidis)
November 25, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services...
Read More
PANTHERx®Rare Selected by Edenbridge Pharmaceuticals as Specialty Pharmacy for Yargesa® (miglustat 100 mg capsules)
April 01, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United...
Read More
PANTHERx® Rare Selected by Chiesi Global Rare Diseases for the Distribution of Filsuvez® (birch triterpenes) topical gel
February 07, 2024
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States,...
Read More
PANTHERx® Rare Pharmacy Once Again Earns Top Ranking in Quarterly MMIT Patient Satisfaction Survey
December 07, 2023
PITTSBURGH – PANTHERx Rare, the six-time winner of the Annual
MMIT Patient Choice Award, once again, has...
Read More
1
2
